Bortezomib

Products Bortezomib is commercially available as a lyophilizate for the preparation of a solution for injection (Velcade). It has been approved in many countries since 2005. Generic versions were registered in 2018. Structure and properties Bortezomib (C19H25BN4O4, Mr = 384.2 g/mol) is a dipeptidyl derivative of boric acid. Effects Bortezomib (ATC L01XX32) has cytotoxic and … Bortezomib